» Articles » PMID: 24888586

Mammary Stem Cells and the Differentiation Hierarchy: Current Status and Perspectives

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2014 Jun 4
PMID 24888586
Citations 308
Authors
Affiliations
Soon will be listed here.
Abstract

The mammary epithelium is highly responsive to local and systemic signals, which orchestrate morphogenesis of the ductal tree during puberty and pregnancy. Based on transplantation and lineage tracing studies, a hierarchy of stem and progenitor cells has been shown to exist among the mammary epithelium. Lineage tracing has highlighted the existence of bipotent mammary stem cells (MaSCs) in situ as well as long-lived unipotent cells that drive morphogenesis and homeostasis of the ductal tree. Moreover, there is accumulating evidence for a heterogeneous MaSC compartment comprising fetal MaSCs, slow-cycling cells, and both long-term and short-term repopulating cells. In parallel, diverse luminal progenitor subtypes have been identified in mouse and human mammary tissue. Elucidation of the normal cellular hierarchy is an important step toward understanding the "cells of origin" and molecular perturbations that drive breast cancer.

Citing Articles

RANK/RANKL Signaling Pathway in Breast Development and Cancer.

Perez-Chacon G, Santamaria P, Redondo-Pedraza J, Gonzalez-Suarez E Adv Exp Med Biol. 2025; 1464():309-345.

PMID: 39821032 DOI: 10.1007/978-3-031-70875-6_16.


ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER breast cancer.

Liang J, Yao X, Aouad P, Wang B, Crocker L, Chaudhuri S Nat Cancer. 2025; 6(2):357-371.

PMID: 39805955 DOI: 10.1038/s43018-024-00898-8.


Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.

Iglesia M, Jayasinghe R, Chen S, Terekhanova N, Herndon J, Storrs E Nat Cancer. 2024; 5(11):1713-1736.

PMID: 39478117 PMC: 11584403. DOI: 10.1038/s43018-024-00773-6.


A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.

Klughammer J, Abravanel D, Segerstolpe A, Blosser T, Goltsev Y, Cui Y Nat Med. 2024; 30(11):3236-3249.

PMID: 39478111 PMC: 11564109. DOI: 10.1038/s41591-024-03215-z.


The molecular chronology of mammary epithelial cell fate switching.

Vallmajo-Martin Q, Ma Z, Srinivasan S, Murali D, Dravis C, Mukund K bioRxiv. 2024; .

PMID: 39415993 PMC: 11482796. DOI: 10.1101/2024.10.08.617155.


References
1.
Maruyama R, Choudhury S, Kowalczyk A, Bessarabova M, Beresford-Smith B, Conway T . Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet. 2011; 7(4):e1001369. PMC: 3080862. DOI: 10.1371/journal.pgen.1001369. View

2.
Bai L, Rohrschneider L . s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev. 2010; 24(17):1882-92. PMC: 2932970. DOI: 10.1101/gad.1932810. View

3.
Fata J, Kong Y, Li J, Sasaki T, Irie-Sasaki J, Moorehead R . The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 2000; 103(1):41-50. DOI: 10.1016/s0092-8674(00)00103-3. View

4.
Melchor L, Molyneux G, Mackay A, Magnay F, Atienza M, Kendrick H . Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. J Pathol. 2014; 233(2):124-37. DOI: 10.1002/path.4345. View

5.
Regan J, Kendrick H, Magnay F, Vafaizadeh V, Groner B, Smalley M . c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. Oncogene. 2011; 31(7):869-83. DOI: 10.1038/onc.2011.289. View